General Information of Drug (ID: DM1D6CQ)

Drug Name
ICI-174864 Drug Info
Synonyms
Ici-174864; Ici 174864; N,N-Diallyl-tyr-aib-phe-leu; N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine; L-Leucine, N-(N-(N-(N,N-di-2-propenyl-L-tyrosyl)-2-methylalanyl)-L-phenylalanyl)-; L-Leucine, N,N-di-2-propenyl-L-tyrosyl-2-methylalanyl-L-phenylalanyl-; AC1Q5QOV; AC1L32KD; SCHEMBL4402752; GTPL1636; PDSP2_001212; PDSP1_001228; n,n-di(prop-2-en-1-yl)-l-tyrosyl-2-methylalanyl-l-phenylalanyl-l-leucine; ICI-174,864; LS-178085
Cross-matching ID
PubChem CID
107691
CAS Number
CAS 89352-67-0
TTD Drug ID
D0B3BJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Autoimmune thyroid disease 2.24 0.00e+0 46/53 (86.79%) PRF1;GZMB;HLA-DRA;...
Allograft rejection 2.24 0.00e+0 32/38 (84.21%) PRF1;GZMB;HLA-DRA;...
Graft-versus-host disease 2.17 0.00e+0 32/42 (76.19%) PRF1;GZMB;KLRD1;...
Viral protein interaction with cytokine and cytokine re... 2.06 2.82e-3 84/100 (84%) TNFSF10;CXCL10;CCL5;...
Viral myocarditis 2.00 2.26e-3 53/60 (88.33%) PRF1;ITGAL;HLA-DRA;...
Asthma 1.97 3.76e-3 25/31 (80.65%) FCER1G;HLA-DRA;HLA-DRB1;...
Cytosolic DNA-sensing pathway 1.95 3.22e-3 52/63 (82.54%) CXCL10;CCL5;AIM2;...
Hematopoietic cell lineage 1.92 2.82e-3 90/99 (90.91%) CD3E;CD14;CD3D;...
Influenza A 1.92 2.51e-3 156/172 (90.7%) TNFSF10;CXCL10;CCL5;...
RIG-I-like receptor signaling pathway 1.87 5.64e-3 64/70 (91.43%) CXCL10;CASP10;IKBKE;...
Natural killer cell mediated cytotoxicity 1.81 1.23e-2 99/131 (75.57%) TNFSF10;PRF1;PIK3CA;...
Th1 and Th2 cell differentiation 1.80 1.50e-2 80/92 (86.96%) RUNX3;IL2RB;STAT4;...
Cytokine-cytokine receptor interaction 1.78 1.65e-2 246/295 (83.39%) TNFSF10;CXCL10;CCL5;...
JAK-STAT signaling pathway 1.76 1.69e-2 146/162 (90.12%) PIK3CA;IL2RB;STAT4;...
Epstein-Barr virus infection 1.76 1.65e-2 189/202 (93.56%) CXCL10;RUNX3;RELB;...
Intestinal immune network for IgA production 1.75 1.62e-2 38/48 (79.17%) HLA-DRA;IL6;TNFRSF17;...
Antigen processing and presentation 1.72 2.59e-2 60/78 (76.92%) HSPA2;CD8A;KLRD1;...
Primary immunodeficiency 1.71 2.51e-2 33/38 (86.84%) CD3E;CD3D;CD8A;...
TNF signaling pathway 1.71 2.61e-2 103/112 (91.96%) CXCL10;CCL5;PIK3CA;...
Chemokine signaling pathway 1.70 2.88e-2 163/192 (84.9%) CXCL10;CCL5;ITK;...
NOD-like receptor signaling pathway 1.68 3.22e-2 145/181 (80.11%) CCL5;AIM2;RHOA;...
Bacterial invasion of epithelial cells 1.67 3.69e-2 59/77 (76.62%) PIK3CA;RHOA;PXN;...
Amoebiasis 1.66 3.58e-2 99/102 (97.06%) PIK3CA;SERPINB9;CD14;...
Hepatitis C 1.65 4.13e-2 139/157 (88.54%) CXCL10;PIK3CA;CLDN8;...
Leukocyte transendothelial migration 1.64 4.51e-2 90/114 (78.95%) ITK;PIK3CA;RHOH;...
T cell receptor signaling pathway 1.62 4.73e-2 93/104 (89.42%) ITK;PIK3CA;CD3E;...
Toll-like receptor signaling pathway 1.61 4.89e-2 94/104 (90.38%) CXCL10;CCL5;PIK3CA;...
GnRH secretion 1.60 4.95e-2 60/64 (93.75%) PIK3CA;GPER1;ITPR1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone marrow
Neuroblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SH-SY5Y CVCL_0019 Homo sapiens 0.04uM - 10uM 24H
SK-N-SH CVCL_0531 Homo sapiens 0.04uM - 10uM 24H